Quarterly certificate for dematerialisation of securities filed with BSE

Compliance View source PDF Explain this filing

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

+4.7%Reaction day

₹174.80

prior close

₹177.50

announcement price

In-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used-2.8%+7.5% vs market

Pesticides & Agrochemicals peers, median of 28sector-2.1%+6.8% vs sector

On the reaction day the stock moved 7.5 pts more than Nifty Microcap 250 and 6.8 pts more than its Pesticides & Agrochemicals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

—

10m

—

15m

—

30m

+0.0

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

+4.7-2.8+7.5-2.1+6.8

Next day

-0.3-2.5+2.2-2.4+2.1

+0.3-1.7+2.0-2.6+2.9

+4.5-1.5+6.0-2.6+7.1

+7.2-0.8+8.0-2.4+9.6

+3.1-2.4+5.5-2.2+5.3

+3.5-3.4+6.9-4.5+8.1

15d

—————

UpDownMarket · Nifty Microcap 250Sector · Pesticides & Agrochemicals peers, median of 28Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Mahamaya Lifesciences has submitted a quarterly compliance certificate under SEBI Regulation 74(5) to BSE for the period ended September 30, 2026. The certificate from registrar KFIN Technologies confirms that all dematerialisation and rematerialisation details have been furnished to stock exchanges. The entire shareholding is held in demat form and no rematerialisation requests were received during the quarter.

Likely market impact

Routine compliance filing with no material impact on shareholders or the stock. Confirms all holdings are in electronic mode.